• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC SOFAMOR DANEK; CEMENT, BONE, VERTEBROPLASTY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC SOFAMOR DANEK; CEMENT, BONE, VERTEBROPLASTY Back to Search Results
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problem No Code Available (3191)
Event Type  Injury  
Manufacturer Narrative
Literature citation: zhi-yong sun, xue-feng li, huan zhao, jun lin, zhong-lai qian, zhi-ming zhang, hui-lin yang; "percutaneous balloon kyphoplasty in treatment of painful osteoporotic occult vertebral fracture: a retrospective study of 89 cases" a2: mean age: 67.5±11.5 ( range: 56-79 years) 55 female and 34 male (b)(4).Neither the device nor applicable imaging films were returned to manufacturer for evaluation therefore we are unable to determine the definitive cause of event.
 
Event Description
It was reported that between 2011 and 2013, 89 patients suffering from painful oovfs( occult osteoporotic vertebral fractures) underwent 142 percutaneous balloon kyphoplasty (pkp) procedures.Outcome data (mean variation of anterior and middle vertebral body height, visual analog scale [vas] scores, oswestry disability index [odi] scores, and sf-36 scores) were recorded preoperatively, postoperatively, and at 1 month, 6 months, and 2 year after treatment, to evaluate the results.We successfully treated 89 patients (142 vertebral bodies) with pkp.The mean variation of anterior and middle vertebral body height changed from 96.5±3.4% preoperatively to 97.2±2.5% postoperatively (p>0.05) and from 96.3±2.8% preoperatively to 97.9±3.1% postoperatively (p>0.05), respectively.The mean vas scores were reduced significantly from pre-surgery to post-surgery (8.3±1.2 to 2.9±0.7; p<(><<)>0.05), as was the odi score (76.4±12.5 to 26.7±5.6; p<(><<)>0.05).The sf-36 scores, including bodily pain (bf), vitality (vt), physical function (pf), and social functioning (sf), all showed notable improvement (p<(><<)>0.05).These variations were maintained during the 2-year follow-up perio d.Hence, pkp is a safe and effective method in the treatment of painful oovfs.Post-operatively 3 adjacent vertebral fractures developed which were associated with cement leakage nearby.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Type of Device
CEMENT, BONE, VERTEBROPLASTY
Manufacturer (Section D)
MEDTRONIC SOFAMOR DANEK
1800 pyramid place
memphis TN 38132
Manufacturer (Section G)
MEDTRONIC SOFAMOR DANEK
1800 pyramid place
memphis TN 38132
Manufacturer Contact
stacie ziemba
1800 pyramid place
memphis, TN 38132
9013963133
MDR Report Key6773043
MDR Text Key82007752
Report Number1030489-2017-01873
Device Sequence Number1
Product Code NDN
Combination Product (y/n)N
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Health Professional
Type of Report Initial
Report Date 07/12/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/08/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/12/2017
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age67 YR
-
-